Development of morphologically dominant follicles is associated with fewer metabolic disturbances in amenorrheic women with polycystic ovary syndrome: A pilot study

Ultrasound in Obstetrics and Gynecology

Volumn 36, Issue 6, 2010, Pages 759-766

  Lujan, M E ^a   Kepley, A L ^a   Chizen, D R ^b   Lehotay, D C ^b   Pierson, R A ^b  

^a Program on Infrastructure Policy   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

folliculogenesis; morphologic selection; polycystic ovary syndrome; transvaginal ultrasonography

Indexed keywords

FOLLITROPIN;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BODY MASS; ECHOGRAPHY; FEMALE; HUMAN; METABOLISM; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY;

ADOLESCENT; ADULT; AMENORRHEA; BODY MASS INDEX; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; OVARIAN FOLLICLE; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 78649676168     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7751     Document Type: Article

References (36)

1. Rotterdam Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
2. Escobar-Morreale HF, San Millan JL,. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 2007; 18: 266-272.
3. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ,. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93: 1276-1284.
4. Himelein MJ, Thatcher SS,. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006; 61: 723-732.
5. Cussons AJ, Stuckey BG, Watts GF,. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006; 185: 227-239.
6. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D,. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003; 18: 598-603.
7. Franks S, Stark J, Hardy K,. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008; 14: 367-378. (Pubitemid 351858976)
8. Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S,. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998; 83: 3984-3991.
9. Fraser IS, Critchley HO, Munro MG, Broder M,. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod 2007; 22: 635-643.
10. Ferriman D, Gallwey JD,. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.
11. Lujan ME, Bloski TG, Chizen DR, Lehotay DC, Pierson RA,. Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome. Hum Reprod 2010; 25: 204-211.
12. Allemand MC, Tummon IS, Phy JL, Foong SC, Dumesic DA, Session DR,. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril 2006; 85: 214-219.
13. Baerwald AR, Adams GP, Pierson RA,. Characterization of ovarian follicular wave dynamics in women. Biol Reprod 2003; 69: 1023-1031.
14. Baerwald AR, Adams GP, Pierson RA,. Form and function of the corpus luteum during the human menstrual cycle. Ultrasound Obstet Gynecol 2005; 25: 498-507.
15. Lujan ME, Brooks ED, Kepley AL, Chizen DR, Pierson RA, Peppin AK,. Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome. Ultrasound Med Biol 2010; 36: 712-718.
16. Nardo LG, Buckett WM, Khullar V,. Determination of the best-fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome. Fertil Steril 2003; 79: 632-633.
17. Diamanti-Kandarakis E, Panidis D,. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol 2007; 67: 735-742.
18. Zhang EY, Zhu FF, Xiong J, Shi XB, Fu SX,. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 2009; 116: 1633-1639.
19. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R,. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83: 1717-1723.
20. Rizzo M, Berneis K, Hersberger M, Pepe I, Di Fede G, Rini GB, Spinas GA, Carmina E,. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 2009; 24: 2286-2292.
21. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S,. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39: 351-355.
22. Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnston DG, Franks S,. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clin Endocrinol 1991; 35: 253-257.
23. Teede HJ, Hutchison S, Zoungas S, Meyer C,. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006; 30: 45-53.
24. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA,. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 2009; 91: 1332-1335.
25. Svendsen PF, Nilas L, Norgaard K, Jensen JE, Madsbad S,. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 2008; 23: 2113-2121.
26. Willis D, Mason H, Gilling-Smith C, Franks S,. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302-309.
27. Baerwald AR, Adams GP, Pierson RA,. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril 2003; 80: 116-122.
28. Lujan ME, Chizen DR, Peppin AK, Dhir A, Pierson RA,. Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement. J Ovarian Res 2009; 2: 6.
29. Lujan ME, Chizen DR, Peppin AK, Kriegler S, Leswick DA, Bloski TG, Pierson RA,. Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries. Reprod Biol Endocrinol 2008; 6: 30.
30. Hecht BR, Hoffman DI,. The use of ultrasound in infertility. Clin Obstet Gynecol 1989; 32: 541-549.
31. Pierson RA, Ginther OJ,. Reliability of diagnostic ultrasonography for identification and measurement of follicles and detecting the corpus luteum in heifers. Theriogenology 1987; 28: 929-936.
32. Pierson RA, Adams GP,. Computer-assisted image analysis, diagnostic ultrasonography and ovulation induction: strange bedfellows. Theriogenology 1995; 43: 105-112.
33. Eissa MK, Hudson K, Docker MF, Sawers RS, Newton JR,. Ultrasound follicle diameter measurement: an assessment of interobserver and intraobserver variation. Fertil Steril 1985; 44: 751-754.
34. Stany MP, Hamilton CA,. Benign disorders of the ovary. Obstet Gynecol Clin North Am 2008; 35: 271-284.
35. Christensena JT, Boldsenb JL, Westergaard JG,. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 2002; 66: 153-157.
36. Borgfeldt C, Andolf E,. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol 1999; 13: 345-350.